Old Web
English
Sign In
Acemap
>
authorDetail
>
Vanderveken J
Vanderveken J
Boehringer Ingelheim
Isolation perfusion
Tumor necrosis factor alpha
Melphalan
Toxicity
Chemotherapy
2
Papers
76
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.
1995
F. Lejeune
Danielle Liénard
A. M. M. Eggermont
Schraffordt Koops H
F. Rosenkaimer
Jean Gerain
Joost M. Klaase
B. B. R. Kroon
Vanderveken J
Paul I.M. Schmitz
Show All
Source
Cite
Save
Citations (26)
Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma.
1994
Journal of Cellular Biochemistry
F. Lejeune
Danielle Liénard
A. M. M. Eggermont
H Schraffordt-Koops
F. Rosenkaimer
Jean Gerain
Joost M. Klaase
B. B. R. Kroon
Vanderveken J
Paul I.M. Schmitz
Show All
Source
Cite
Save
Citations (50)
1